Table 1 Associations between RBM3 and PODXL expression and clinicopathological characteristics
PODXL Expression (n = 262) | RBM3 expression (n = 259) | |||||
|---|---|---|---|---|---|---|
Non-membranous | Membranous | Low (NS = 0–4) | High (NS = 6–9) | |||
N (%) | 235 (89.7%) | 27 (10.3%) | p-value | 104 (40.2%) | 155 (59.8%) | p-value |
Age | ||||||
Mean/median | 71.4/71.4 | 71.2/72.4 | 0.933 | 72.2/72.5 | 70.6/70.5 | 0.069 |
Range | 51.2–86.6 | 56.2–86.8 | 51.3–86.8 | 51.2–86.6 | ||
Sex | ||||||
Female | 67 (84.8%) | 12 (15.2%) | 0.088 | 32 (40.0%) | 48 (60.0%) | 0.973 |
Male | 168 (91.8%) | 15 (8.2%) | 72 (40.2%) | 107 (59.8%) | ||
T-stage | ||||||
Ta | 113 (100.0%) | 0 (0.0%) | <0.001 | 30 (26.3%) | 84 (73.7%) | <0.001 |
T1 | 73 (88.0%) | 10 (12.0%) | 28 (34.6%) | 53 (65.4%) | ||
T2–4 | 49 (74.2%) | 17 (25.8%) | 46 (71.9%) | 18 (28.1%) | ||
Grade | ||||||
Low | 128 (99.2%) | 1 (0.8%) | <0.001 | 27 (20.8%) | 103 (79.2%) | <0.001 |
High | 107 (80.5%) | 26 (19.5%) | 77 (59.7%) | 52 (40.3%) | ||